NJ Pharma Co. Settles Price-Fixing Charges For $3M

Law360 (December 3, 2019, 9:39 PM EST) -- Rising Pharmaceuticals Inc. will pay over $3 million to resolve criminal and civil charges related to a price-fixing scheme involving a hypertension drug, making it the latest entity ensnared in a long-running criminal probe of generics makers, the U.S. Department of Justice said Tuesday.

The New Jersey-based company agreed to enter into a deferred prosecution agreement over a felony charge in Pennsylvania federal court accusing it of conspiring with a competing business to fix prices and allocate customers for Benazepril HCTZ, the DOJ said. The scheme unfolded between April 2014 and at least September 2015, the agency said.

“Rising and its...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS